Vera Therapeutics, Inc. · NASDAQ:VERA
Deep Track Capital, LP reported a 9.71% stake in Vera Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Deep Track Capital, LP reported a 9.71% stake in Vera Therapeutics, Inc., 7,000,000 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 9.71%
- Shares
- 7,000,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 9.71% | 7,000,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 9.71% | 7,000,000 |
| David Kroin | 9.71% | 7,000,000 |
Source
Download original · View original at SEC
Related
- Vera Therapeutics, Inc.
- Deep Track Capital, LP
- Vera Therapeutics, Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · Mar 11, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 16, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Form 4 · Fordyce Marshall · Sep 17, 2026
- Form 4 · Young Joseph R · Sep 14, 2026